Roche Holding AG (RHHBF) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - General industria. La empresa tiene su sede en Basel, Switzerland. El CEO actual es Thomas Schinecker.
RHHBF tiene fecha de IPO 2012-08-03, 103,249 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $333.13B.
Roche Holding AG is a Swiss-based pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, immunology, cardiovascular, ophthalmology, and respiratory diseases, as well as treatments for conditions such as cancer, hemophilia, and inflammatory disorders. Roche also operates a substantial diagnostics business providing in vitro testing for disease diagnosis, including cancer, diabetes, COVID-19, and hepatitis, alongside diagnostic instruments and reagents. With operations spanning Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and other international markets, Roche maintains research collaborations to develop innovative therapies, including synthetic biologics for inflammatory bowel disease treatment.
